Surfactant treatment in experimental hyaline membrane disease

R. Nilsson, G. Grossmann, P. Berggren, B. Robertson

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Premature newborn rabbits obtained by hysterotomy on day 27 of gestation were ventilated artificially under standardized conditions, serving as experimental model of neonatal hyaline membrane disease. Natural surfactant with a phosphoid concentration of approximately 8 mg/ml was administered as 50-μl doses after 10 min of ventilation and at subsequent 30-min intervals. Initial values for lung-thorax compliance were significantly improved following two doses of surfactant, whereas compliance levels of non-treated littermates remained unchanged. Treatment with surfactants resulted in increased alveolar air expansion. Bronchiolar epithelial lesions were present in both surfactant-treated animals and controls, but the severity of these lesions was clearly reduced after surfactant treatment. We conclude that surfactant substitution is an effective treatment in experimental hyaline membrane disease, even when given after an initial period of artificial ventilation.

Original languageEnglish (US)
Pages (from-to)441-449
Number of pages9
JournalEuropean Journal of Respiratory Diseases
Volume62
Issue number6
StatePublished - Dec 1 1981

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Surfactant treatment in experimental hyaline membrane disease'. Together they form a unique fingerprint.

  • Cite this

    Nilsson, R., Grossmann, G., Berggren, P., & Robertson, B. (1981). Surfactant treatment in experimental hyaline membrane disease. European Journal of Respiratory Diseases, 62(6), 441-449.